Quaker Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Buy
2,138
+223
+12% +$12.8K 0.04% 98
2026
Q1
$116K Sell
1,915
-183
-9% -$10.7K 0.04% 102
2025
Q4
$113K Buy
2,098
+217
+12% +$10.4K 0.04% 107
2025
Q3
$84.8K Sell
1,881
-33
-2% -$1.54K 0.03% 116
2025
Q2
$88.6K Buy
+1,914
New +$94K 0.03% 117
2024
Q1
$258K Buy
4,758
+172
+4% +$8.76K 0.1% 46
2023
Q4
$235K Sell
4,586
-1,338
-23% -$70.2K 0.11% 46
2023
Q3
$344K Buy
5,924
+1,909
+48% +$117K 0.17% 34
2023
Q2
$257K Buy
4,015
+1,109
+38% +$74.4K 0.12% 38
2023
Q1
$201K Sell
2,906
-9
-0.3% -$635 0.09% 46
2022
Q4
$210K Buy
2,915
+7
+0.2% +$528 0.11% 37
2022
Q3
$207K Sell
2,908
-192
-6% -$13.9K 0.11% 38
2022
Q2
$239K Buy
3,100
+7
+0.2% +$533 0.12% 36
2022
Q1
$226K Sell
3,093
-1,392
-31% -$93.5K 0.1% 46
2021
Q4
$280K Buy
+4,485
New +$263K 0.12% 38
2020
Q1
Sell
-3,120
Closed -$200K 41
2019
Q4
$200K Buy
+3,120
New +$179K 0.12% 48

Other funds holding BMY

Quaker Wealth Management's BMY Position: Q2 2026 in Review

Quaker Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $12.8K and bringing the position to 2,138 shares worth $123K. The position accounts for 0.04% of the portfolio, ranked #98.

Quaker Wealth Management first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $344K in Q3 2023. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Quaker Wealth Management held 2,138 shares of Bristol-Myers Squibb worth $123K as of Q2 2026.
  • Quaker Wealth Management bought 223 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.8K.
  • Bristol-Myers Squibb made up 0.04% of Quaker Wealth Management's portfolio in Q2 2026, its #98 holding.
  • Quaker Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
  • Quaker Wealth Management's Bristol-Myers Squibb position peaked at $344K in Q3 2023.
  • 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.